
|Articles|June 1, 2004
- Volume 0 0
dual path
Advertisement
Articles in this issue
over 21 years ago
Examover 21 years ago
Managed Care Commentary:MCOs face new challengesover 21 years ago
Phytosterols may play role in atherosclerosisover 21 years ago
Dual pathway inhibition: Attacking cholesterol on two frontsover 21 years ago
Future Goals, Targets, and Treatments of DyslipidemiaNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























